RECOMBINANT HUMAN ERYTHROPOIETIN (R-HUEPO) ACTIVATES A BROAD-SPECTRUM OF HEMATOPOIETIC STEM-CELLS

被引：0
|
作者：
STOCKENHUBER, F
GEISSLER, K
SUNDERPLASSMANN, G
KURZ, RW
JAHN, C
HINTERBERGER, W
BALCKE, P
机构：
[1] VIENNA UNIV,DEPT MED 1,A-1010 VIENNA,AUSTRIA
[2] KAISER FRANZ JOSEPH HOSP,VIENNA,AUSTRIA
来源：
KIDNEY INTERNATIONAL | 1989年 / 35卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：321 / 321
页数：1
相关论文
共 50 条
  • [31] Development of a sensitive size exclusion HPLC method with fluorescence detection for the quantitation of recombinant human erythropoietin (r-HuEPO) aggregates
    Gunturi, Srinivas R.
    Ghobrial, Ibrahim
    Sharma, Basant
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2007, 43 (01) : 213 - 221
  • [32] EXERCISE CAPACITY IN HEMODIALYSIS-PATIENTS UNDER LONG-TERM TREATMENT WITH RECOMBINANT HUMAN ERYTHROPOIETIN (R-HUEPO)
    MAYER, G
    CADA, EM
    BARNAS, U
    LUDVIK, G
    GRAF, H
    CLINICAL RESEARCH, 1989, 37 (01): : A148 - A148
  • [33] PREDICTION OF RESPONSE TO RECOMBINANT-HUMAN-ERYTHROPOIETIN (R-HUEPO/EPOETIN-ALPHA) THERAPY IN CANCER-PATIENTS
    HENRY, D
    ABELS, R
    LARHOLT, K
    BLOOD, 1995, 85 (06) : 1676 - 1678
  • [34] REGRESSION OF LEFT-VENTRICULAR HYPERTROPHY (LVH) IN DIALYSIS PATIENTS FOLLOWING CORRECTION OF ANEMIA WITH RECOMBINANT HUMAN ERYTHROPOIETIN (R-HUEPO)
    BARRE, P
    SILBERBERG, J
    RACINE, N
    WONG, C
    SNIDERMAN, A
    KIDNEY INTERNATIONAL, 1990, 37 (01) : 288 - 288
  • [35] Mobilization of ferritin in iron-loading anemia acquired immunodeficiency syndrome (AIDS) patients with recombinant human erythropoietin (r-HuEPO).
    McPherson, E
    Patti, S
    Mejia, E
    Hazel, E
    BLOOD, 1998, 92 (10) : 19B - 19B
  • [36] CORRECTION OF ANEMIA BY RECOMBINANT HUMAN ERYTHROPOIETIN (R-HUEPO) ENHANCES WORKING CAPACITY AND EXERCISE TOLERANCE IN PATIENTS ON CHRONIC-HEMODIALYSIS
    GRAF, H
    MAYER, G
    CADA, E
    THUM, J
    STUMMVOLL, HK
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1988, 11 (01) : A8 - A8
  • [37] Faster oxygen uptake kinetics at the onset of submaximal cycling exercise following 4 weeks recombinant human erythropoietin (r-HuEPO) treatment
    Connes, P
    Perrey, S
    Varray, A
    Préfaut, C
    Caillaud, C
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2003, 447 (02): : 231 - 238
  • [38] Faster oxygen uptake kinetics at the onset of submaximal cycling exercise following 4 weeks recombinant human erythropoietin (r-HuEPO) treatment
    Philippe Connes
    Stéphane Perrey
    Alain Varray
    Christian Préfaut
    Corinne Caillaud
    Pflügers Archiv, 2003, 447 : 231 - 238
  • [39] RAISED HEMATOCRIT (HCT) PERSISTS 6-WEEKS AFTER STOPPING TREATMENT WITH HUMAN RECOMBINANT ERYTHROPOIETIN (R-HUEPO) IN AZOTEMIC, ANEMIC PATIENTS
    BROWN, CD
    KIERAN, M
    DOSUNMU, BV
    ZHAO, ZH
    LARSON, RH
    FRIEDMAN, EA
    KIDNEY INTERNATIONAL, 1988, 33 (01) : 184 - 184
  • [40] Recombinant human erythropoietin (r-HuEPO) is effective in treating anemia associated with the acquired immunodeficiency syndrome (AIDS) in patients not receiving concomitant zidovudine (AZT).
    Makower, D
    Subar, M
    BLOOD, 1996, 88 (10) : 3287 - 3287
12345